Wright Investors Service Comprehensive Report for Pernix Therapeutics Holdings Incorporated
05 Aug 2016
Available for Immediate Download
Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio tables (Accounting, Asset Utilization, Employee Efficiency, Fixed Charges Coverage, Leverage Analysis, Liquidity Analysis, Per-share Data and Profitability Analysis) and proprietary Wright Quality RatingÂ® analyses tables. The Wright Quality Rating measures the liquidity of the stock and the financial strength, profitability and corporate growth characteristics of Pernix Therapeutics Holdings Incorporated A textual review of the financial results of Pernix Therapeutics Holdings Incorporated versus MusclePharm Corp, Newlink Genetics Corporation and FibroGen Inc is includedrepo. The comparative analysis,of these companies,compares Sales, Company Valuations and Financial Position. Also included for Pernix Therapeutics Holdings Incorporated are: Company Description, Recent Stock Performance, Profitability Analysis, Dividend Analysis, and key data items. Additional research for Pernix Therapeutics Holdings Incorporated includes tables with up to 10-years of history of computed ratios, sales, earnings, and security prices. The companyâ€™s financial results are compared in a series of reports (i.e. financial statements, sales, key ratios, etc.) to global industry averages.